|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/08 | |
| A61K 9/19 | |||
| A61K 47/02 | |||
| A61K 47/20 | |||
| A61K 38/26 | |||
| A61P 5/48 |
| (11) | Number of the document | 3102184 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15706976.6 |
| Date of filing the European patent application | 2015-02-06 | |
| (97) | Date of publication of the European application | 2016-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/014756 |
| Date | 2015-02-06 |
| (87) | Number | WO 2015/120231 |
| Date | 2015-08-13 |
| (30) | Number | Date | Country code |
| 201461936675 P | 2014-02-06 | US |
| (72) |
PRESTRELSKI, Steven, US
DONOVAN, Martin, US
|
| (73) |
Xeris Pharmaceuticals, Inc.,
3208 Red River, Suite 300, Austin TX 78705,
US
|
| (54) | STABLE PEPTIDE FORMULATIONS AND METHODS FOR PREPARATION |
| STABLE PEPTIDE FORMULATIONS AND METHODS FOR PREPARATION |